Sutro Biopharma, Inc. (STRO) is a publicly traded Healthcare sector company. As of May 21, 2026, STRO trades at $30.52 with a market cap of $571.35M and a P/E ratio of -1.26. STRO moved -1.80% today. Year to date, STRO is +186.38%; over the trailing twelve months it is +246.00%. Its 52-week range spans $5.23 to $46.00. Analyst consensus is strong buy with an average price target of $47.50. Rallies surfaces STRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sutro Biopharma, Inc. (STRO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. STRO moved -1.80% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $30.52 |
| Market Cap | $571.35M |
| P/E Ratio | -1.26 |
| EPS | $-24.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.00 |
| 52-Week Low | $5.23 |
| Volume | 120 |
| Avg Volume | 0 |
| Revenue (TTM) | $99.61M |
| Net Income | $-153.60M |
| Gross Margin | 0.00% |
9 analysts cover STRO: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.50.